Related references
Note: Only part of the references are listed.Frequency of Blood-Brain Barrier Disruption Post-Endovascular Therapy and Multiple Thrombectomy Passes in Acute Ischemic Stroke Patients
Marie Luby et al.
STROKE (2019)
The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Lu Wang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
Targeting Reperfusion Injury in the Age of Mechanical Thrombectomy
Atsushi Mizuma et al.
STROKE (2018)
Quantifying Infarct Growth and Secondary Injury Volumes: Comparing Multimodal Image Registration Measures
George W. J. Harston et al.
STROKE (2018)
The Accuracy of Serum Matrix Metalloproteinase-9 for Predicting Hemorrhagic Transformation After Acute Ischemic Stroke: A Systematic Review and Meta-Analysis
Lu Wang et al.
JOURNAL OF STROKE & CEREBROVASCULAR DISEASES (2018)
MiR-539 Targets MMP-9 to Regulate the Permeability of Blood-Brain Barrier in Ischemia/Reperfusion Injury of Brain
Feng Fan et al.
NEUROCHEMICAL RESEARCH (2018)
Reconsidering Neuroprotection in the Reperfusion Era
Sean I. Savitz et al.
STROKE (2017)
Vessel Wall Enhancement and Blood-Cerebrospinal Fluid Barrier Disruption After Mechanical Thrombectomy in Acute Ischemic Stroke
Arturo Renu et al.
STROKE (2017)
Hemorrhagic Transformations after Thrombectomy: Risk Factors and Clinical Relevance
Johannes Kaesmacher et al.
CEREBROVASCULAR DISEASES (2017)
Revisiting cerebral postischemic reperfusion injury: new insights in understanding reperfusion failure, hemorrhage, and edema
Jilin Bai et al.
INTERNATIONAL JOURNAL OF STROKE (2015)
Final infarct volume estimation on 1-week follow-up MR imaging is feasible and is dependent on recanalization status
Mark Krongold et al.
NEUROIMAGE-CLINICAL (2015)
proMetalloproteinase-10 is associated with brain damage and clinical outcome in acute ischemic stroke
J. A. Rodriguez et al.
JOURNAL OF THROMBOSIS AND HAEMOSTASIS (2013)
MMP9 Variation After Thrombolysis Is Associated With Hemorrhagic Transformation of Lesion and Death
Domenico Inzitari et al.
STROKE (2013)
Intravenous Minocycline in Acute Stroke A Randomized, Controlled Pilot Study and Meta-analysis
Edith Kohler et al.
STROKE (2013)
Relationship between plasma metalloproteinase-9 levels and volume and severity of infarct in patients with acute ischemic stroke
Recep Demir et al.
ACTA NEUROLOGICA BELGICA (2012)
Temporal profile of molecular signatures associated with circulating endothelial progenitor cells in human ischemic stroke
Tomas Sobrino et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2012)
Final Cerebral Infarct Volume Is Predictable by MR Imaging at 1 Week
T. Tourdias et al.
AMERICAN JOURNAL OF NEURORADIOLOGY (2011)
Biochemical Markers for Blood-Brain Barrier Dysfunction in Acute Ischemic Stroke Correlate with Evolution and Outcome
Raf Brouns et al.
EUROPEAN NEUROLOGY (2011)
Matrix Metalloproteinase-9 in an Exploratory Trial of Intravenous Minocycline for Acute Ischemic Stroke
Jeffrey A. Switzer et al.
STROKE (2011)
The Temporal Profile of Inflammatory Markers and Mediators in Blood after Acute Ischemic Stroke Differs Depending on Stroke Outcome
H. Worthmann et al.
CEREBROVASCULAR DISEASES (2010)
Diffusion-weighted MRI in acute stroke within the first 6 hours 1.5 or 3.0 Tesla?
C. Rosso et al.
NEUROLOGY (2010)
Blood-Brain Barrier Disruption in Humans Is Independently Associated With Increased Matrix Metalloproteinase-9
Taura L. Barr et al.
STROKE (2010)
Minocycline and hypothermia for reperfusion injury after focal cerebral ischemia in the rat - Effects on BBB breakdown and MMP expression in the acute and subacute phase
Simon Nagel et al.
BRAIN RESEARCH (2008)
Oxidative stress and matrix metalloproteinase-9 in acute ischemic stroke - The biomarker evaluation for antioxidant therapies in stroke (BEAT-stroke) study
Peter J. Kelly et al.
STROKE (2008)
Serum cellular fibronectin and matrix metalloproteinase-9 as screening biomarkers for the prediction of parenchymal hematoma after thrombolytic therapy in acute ischemic stroke -: A multicenter confirmatory study
Mar Castellanos et al.
STROKE (2007)
3-tesla versus 1.5-tesla magnetic resonance diffusion and perfusion imaging in hyperacute ischemic stroke
Robert K. Kosior et al.
CEREBROVASCULAR DISEASES (2007)
Increased brain expression of matrix metalloproteinase-9 after ischemic and hemorrhagic human stroke
Anna Rosell et al.
STROKE (2006)
Association between tPA therapy and raised early matrix metalloproteinase-9 in acute stroke
M. Ning et al.
NEUROLOGY (2006)
A matrix metalloproteinase protein array reveals a strong relation between MMP-9 and MMP-13 with diffusion-weighted image lesion increase in human stroke
A Rosell et al.
STROKE (2005)
Predicting final infarct size using acute and subacute multiparametric MRI measurements in patients with ischemic stroke
M Lu et al.
JOURNAL OF MAGNETIC RESONANCE IMAGING (2005)
Acute and subacute ischemic stroke at high-field-strength (3.0-T) diffusion-weighted MR imaging: Intraindividual comparative study
CK Kuhl et al.
RADIOLOGY (2005)
Early blood-brain barrier disruption in human focal brain ischemia
LL Latour et al.
ANNALS OF NEUROLOGY (2004)
Closure of the blood-brain barrier by matrix metalloproteinase inhibition reduces rtPA-mediated mortality in cerebral ischemia with delayed reperfusion
T Pfefferkorn et al.
STROKE (2003)
Trial design and reporting standards for intra-arterial cerebral thrombolysis for acute ischemic stroke
RT Higashida et al.
STROKE (2003)
Matrix metalloproteinase-9 pretreatment level predicts intracranial hemorrhagic complications after thrombolysis in human stroke
J Montaner et al.
CIRCULATION (2003)
Plasma metalloproteinase-9 concentration predicts hemorrhagic transformation in acute ischemic stroke
M Castellanos et al.
STROKE (2003)
Plasmatic level of neuroinflammatory markers predict the extent of diffusion-weighted image lesions in hyperacute stroke
J Montaner et al.
JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM (2003)
Involvement of matrix metalloproteinase in thrombolysis-associated hemorrhagic transformation after embolic focal ischemia in rats
T Sumii et al.
STROKE (2002)
Matrix metalloproteinase inhibitor KB-R7785 attenuates brain damage resulting from permanent focal cerebral ischemia in mice
XF Jiang et al.
NEUROSCIENCE LETTERS (2001)
Validity and reliability of a quantitative computed tomography score in predicting outcome of hyperacute stroke before thrombolytic therapy
PA Barber et al.
LANCET (2000)
Share Paper
